Imaging Dynamics Company Ltd.

Imaging Dynamics Company Ltd., a medical technology company, provides digital radiography equipment in the Americas and internationally. The company offers imaging detectors; and flat panel detectors under Aquarius 8600 and VetnovaXion names. It also provides Magellan, a medical image processing software; and Sirius, a veterinary image processing software. In addition, the company provides 1600 Plus X-Series, a DR solution with a floor mounted U-arm multi-axis positioning device that includes X-ray tube, collimator, and generator; and veterinary DR systems. It offers products through dealers, distributors, and original equipment manufacturer partners. The company was formerly known as Imaging Dynamics Corporation and changed its name to Imaging Dynamics Company Ltd. in October 2001. Imaging Dynamics Company Ltd. was incorporated in 1995 and is headquartered in Toronto, Canada.

Imaging Dynamics Company Ltd. trades as IDYLF on OTC. The company is classified in Healthcare / Medical - Devices and reports in USD.

The current profile places the business in Medical - Devices. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $107,853 of revenue and -$569,348 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Imaging Dynamics Company Ltd. can be compared against peers such as Bangi Inc., Biophytis S.A., Dynatronics Corporation, Mednow Inc., Modern Mobility Aids, Inc., nDatalyze Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $242,862, beta of -0.27, and return on equity of +9.8%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IDYLF currently shows total debt of $4.82M and beta of -0.27. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.imagingdynamics.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.